CH451126A - Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden - Google Patents
Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroidenInfo
- Publication number
- CH451126A CH451126A CH76263A CH76263A CH451126A CH 451126 A CH451126 A CH 451126A CH 76263 A CH76263 A CH 76263A CH 76263 A CH76263 A CH 76263A CH 451126 A CH451126 A CH 451126A
- Authority
- CH
- Switzerland
- Prior art keywords
- steroids
- formyl
- oxo
- preparation
- enol ethers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Manufacturing Of Electric Cables (AREA)
- Insulated Conductors (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3001/62A GB1005639A (en) | 1962-01-26 | 1962-01-26 | 2(3)-unsaturated 3-enol ethers of 2-formyl-3-oxo-5ª-steroids and process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CH451126A true CH451126A (de) | 1968-05-15 |
Family
ID=9750081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH76263A CH451126A (de) | 1962-01-26 | 1963-01-22 | Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden |
Country Status (8)
Country | Link |
---|---|
US (2) | US3160643A (de) |
BR (1) | BR6346445D0 (de) |
CH (1) | CH451126A (de) |
DE (1) | DE1443466A1 (de) |
DK (2) | DK107162C (de) |
FR (2) | FR1572954A (de) |
GB (1) | GB1005639A (de) |
NO (1) | NO123131B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3415852A (en) * | 1965-08-20 | 1968-12-10 | American Cyanamid Co | Method of preparing 3-alkoxy-2-formyl-delta2-steroids and new products resulting therefrom |
US3562260A (en) * | 1965-08-23 | 1971-02-09 | Ormonoterapia Richter Spa | 2-carbonyl-estratrienes and method of their preparation |
-
1962
- 1962-01-26 GB GB3001/62A patent/GB1005639A/en not_active Expired
-
1963
- 1963-01-22 DE DE19631443466 patent/DE1443466A1/de active Pending
- 1963-01-22 CH CH76263A patent/CH451126A/de unknown
- 1963-01-23 NO NO147219A patent/NO123131B/no unknown
- 1963-01-24 US US253750A patent/US3160643A/en not_active Expired - Lifetime
- 1963-01-24 US US253751A patent/US3155692A/en not_active Expired - Lifetime
- 1963-01-24 FR FR1572954D patent/FR1572954A/fr not_active Expired
- 1963-01-24 FR FR1572107D patent/FR1572107A/fr not_active Expired
- 1963-01-25 DK DK36763AA patent/DK107162C/da active
- 1963-01-25 BR BR146445/63A patent/BR6346445D0/pt unknown
- 1963-01-25 DK DK37063AA patent/DK109326C/da active
Also Published As
Publication number | Publication date |
---|---|
DE1443466A1 (de) | 1969-01-30 |
NO123131B (de) | 1971-10-04 |
DK109326C (da) | 1968-04-16 |
BR6346445D0 (pt) | 1973-07-03 |
DK107162C (da) | 1967-05-01 |
US3160643A (en) | 1964-12-08 |
FR1572107A (de) | 1969-06-27 |
US3155692A (en) | 1964-11-03 |
GB1005639A (en) | 1965-09-22 |
FR1572954A (de) | 1969-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH457490A (de) | Verfahren zur Herstellung von N-Acylcysteinen | |
CH430677A (de) | Verfahren zur Herstellung von p-Aminoarylaldehyden | |
CH464206A (de) | Verfahren zur Herstellung von -Aminobenzylpenicillinen | |
CH435303A (de) | Verfahren zur Herstellung von 2-Chlor-s-triazinen | |
CH451126A (de) | Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden | |
AT250582B (de) | Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden | |
CH431511A (de) | Verfahren zur Herstellung von 1a-Alkylthio-3-keto-steroiden | |
CH429729A (de) | Verfahren zur Herstellung von Aminoisoxazolen | |
CH427812A (de) | Verfahren zur Herstellung von Oxathiazolinonen | |
CH450405A (de) | Verfahren zur Herstellung von 19-Hydroxy- 4-3-keto-steroiden | |
CH476707A (de) | Verfahren zur Herstellung von 3-Enoläthern von 6-Formyl-3-oxo- 4-steroiden | |
AT241433B (de) | Verfahren zur Herstellung von N-Trifluormethyl-N-aryl-aminosulfensäurehalogeniden | |
CH441349A (de) | Verfahren zur Herstellung von s-Tetrazinen | |
CH440265A (de) | Verfahren zur Herstellung von 19-Norsteroiden | |
CH443283A (de) | Verfahren zur Herstellung von 3-Methylen-steroidenn | |
CH431518A (de) | Verfahren zur Herstellung von 16B-Niederalkylthio-17B-hydroxy-östren-3-onen | |
AT257064B (de) | Verfahren zur Herstellung von 16α-Hydroxysteroiden | |
AT242149B (de) | Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin | |
CH431510A (de) | Verfahren zur Herstellung von Diacylcymarol | |
CH409978A (de) | Verfahren zur Herstellung von 1-Aryl-hydropyrazolen | |
CH435302A (de) | Verfahren zur Herstellung von 3-Alkoxy-4-nitro-6-alkylpyridazin-1-oxyden | |
CH430735A (de) | Verfahren zur Herstellung von 2-Hydroxy-s-triazinen | |
CH428750A (de) | Verfahren zur Herstellung von N-Trifluormethylaminen | |
CH478110A (de) | Verfahren zur Herstellung von 5a- 1-Androstenolen | |
CH441298A (de) | Verfahren zur Herstellung von 8B-Methyl-11B-oxysteroiden |